Paul Saladino· MD
we should probably have a sense of where we are on the igf-1 curve and be checking that metric frequently
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
we should probably have a sense of where we are on the igf-1 curve and be checking that metric frequently
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it's it's kind of hard to and frankly I don't even know how to elucidate like a super clear way that is completely accurate but it's it seems to be kind of uh when one is high the other one would be low and conversely in order to kind of maintain a not necessarily at the same times but to m maintain like a balancing act in the body
when you have elevated igf-1 it will give negative feedback and there is an elevation something called somat Statin which is like basically tells your body don't make as much GH essentially